褪黑激素市场按来源、类型、最终用户和地区划分（2026 年至 2032 年）

褪黑激素市场评估（2026-2032）

随着人们对睡眠障碍的认识不断提高以及褪黑素补充剂的益处日益凸显，褪黑素产业正在迅速扩张。压力水平的上升、老年人口的增长以及人们对自然疗法的追求，都推动了市场的成长。北美市场占有率。因此，预计2024年市场规模将超过18.6亿美元，到2032年将达到约49.3亿美元。

褪黑素配方技术的进步和线上零售业的蓬勃发展正在推动市场扩张。对客製化健康和保健解决方案的需求也推动了市场需求的成长。 Natrol、Life Extension 和 Swanson Health Products 是主要的市场参与企业，它们正在透过产品创新和策略联盟巩固其市场地位。褪黑素需求的不断增长，使得市场在 2026 年至 2032 年期间的复合年增长率达到 14.30%。

褪黑激素市场定义/概述

褪黑激素是一种由大脑松果体分泌的天然激素，能够调节睡眠-觉醒週期。它通常被用作膳食补充剂，透过促进放鬆和改善睡眠品质来帮助治疗与睡眠障碍、时差反应和轮班工作相关的问题。

褪黑激素常用于调节睡眠-觉醒週期、治疗失眠和预防时差反应。它也用于治疗儿童睡眠障碍、术前焦虑以及轮班工人的睡眠巩固。褪黑激素还具有抗氧化特性，可能有助于改善眼睛健康和季节性情感障碍 (SAD)。

除了调节睡眠，褪黑素的未来用途还可能包括缓解情绪障碍、时差反应和增强免疫力。随着对其抗氧化和抗发炎特性的研究不断深入，褪黑素或将拥有更广泛的药用价值，并在整体健康和保健策略中发挥更重要的作用。

人们对睡眠障碍的认识不断提高会推动褪黑激素市场的成长吗？

鑑于睡眠障碍在美国的盛行率很高，人们对睡眠障碍认识的提高将显着促进褪黑激素市场的成长。

根据美国疾病管制与预防中心 (CDC) 的数据，约有 7,000 万美国患有慢性睡眠问题，包括失眠、睡眠呼吸中止症和睡眠不足等多种症状。美国睡眠美国的数据显示，美国有 5,000 万至 7,000 万成年人患有一种或多种睡眠问题。

这种日益增长的认识导致消费者对褪黑激素补充剂的需求增加，并加深了对褪黑激素在调节睡眠模式和改善整体睡眠品质方面的作用的认识。美国国家卫生统计中心报告称，2007 年至 2012 年间，美国褪黑激素补充剂的使用量显着增加，从人口的 0.6% 增加到 1.3%，增加了一倍多。这一发展反映了人们越来越倾向于自然健康疗法和量身定制的健康解决方案，褪黑激素补充剂越来越受欢迎，因为它们被认为可有效治疗睡眠障碍。随着人们认识的提高以及褪黑激素产品配方和分销管道的发展，市场可能会进一步扩大，以满足不断增长的客户需求和偏好。

安全性问题和日益增加的副作用是否会阻碍褪黑激素市场的发展？

褪黑素使用相关的安全隐患和不良反应日益增多，可能会阻碍该行业的发展。虽然褪黑素通常被认为对成人短期使用是安全的，但其长期安全性以及与其他药物可能产生的相互作用仍存在疑问。虽然观察到了日间嗜睡、头痛和头晕等不良症状，但并不常见。此外，全球监管环境不同，导致标准和监管也存在差异，可能会损害消费者信心。

透过严谨的研究、更完善的标籤以及对医疗保健专业人员的教育来解决这些安全问题，对于避免重大的市场损失至关重要。在人们健康意识日益增强、助眠产品需求日益旺盛的背景下，公开潜在风险和益处的透明度以及合理的营销策略，对于维护消费者信任并确保褪黑素行业持续扩张至关重要。

目录

第一章 引言

• 市场定义
• 细分市场
• 分析方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 褪黑素市场（依来源）

• 植物
• 动物
• 细菌

第五章 褪黑激素市场（依类型）

• 天然褪黑激素
• 合成褪黑激素

第六章 褪黑素市场（依最终用户）

• 製药
• 食品/饮料
• 医疗保健

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• 感染疾病 -19对市场的影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici SPA

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Melatonin Market Valuation - 2026-2032

The melatonin industry is expanding rapidly, driven by increased awareness of sleep disorders and the benefits of melatonin supplementation. Rising stress levels, a growing older population, and a shift toward natural health therapies are all contributing to market growth. North America offers a significant market share. This is likely to enable the market size surpass USD 1.86 Billion valued in 2024 to reach a valuation of around USD 4.93 Billion by 2032.

Technological advances in melatonin product formulations, as well as the growing online retail sector, are driving market expansion. The push toward tailored health and wellness solutions is also driving up demand. Natrol, Life Extension, and Swanson Health Products are key industry participants that rely on product innovation and strategic collaborations to strengthen their market positions. The rising demand for Melatonin is enabling the market grow at a CAGR of 14.30% from 2026 to 2032.

Melatonin Market: Definition/ Overview

Melatonin is a natural hormone produced by the pineal gland in the brain that regulates the sleep-wake cycle. It is commonly used as a dietary supplement to assist treat sleep disorders, jet lag and shift work-related concerns by encouraging relaxation and enhancing sleep quality.

Melatonin is generally used to regulate sleep-wake cycles, treat insomnia, and prevent jet lag. It is also used to treat sleep abnormalities in children, anxiety prior to surgery, and enhancing sleep in shift workers. Melatonin also possesses antioxidant capabilities that may aid eye health and seasonal affective disorder (SAD).

Melatonin's future applications may include mood disorders, jet lag, and immunological support, in addition to sleep regulation. Ongoing research into its antioxidant and anti-inflammatory qualities may lead to larger medicinal applications, bolstering its significance in holistic health and wellness strategies.

Will Increasing Awareness of Sleep Disorders Boost the Melatonin Market Growth?

Increasing awareness of sleep disorders is poised to significantly boost the melatonin market growth due to the substantial prevalence of these conditions among the American population.

According to the Centers for Disease Control and Prevention (CDC), around 70 million Americans suffer from chronic sleep issues, which include a variety of illnesses such as insomnia, sleep apnea and inadequate sleep length. According to the American Sleep Association, 50-70 million adults in the United States suffer from one or more sleep problems.

This increasing awareness is translating into increased consumer demand for melatonin supplements, which is driven by a better knowledge of melatonin's role in regulating sleep patterns and improving overall sleep quality. From 2007 to 2012, the National Center for Health Statistics reported a significant increase in melatonin supplement use in the United States, more than doubling from 0.6% to 1.3% of the population. This development mirrors a broader shift toward natural health therapies and individualized wellness solutions, with melatonin supplements becoming increasingly popular for their perceived effectiveness in treating sleep disturbances. As awareness grows, along with developments in melatonin product formulations and distribution channels, the market is likely to expand further to accommodate expanding customer wants and preferences.

Will Increasing Safety Issues and Adverse Effects Hamper the Melatonin Market?

Increasing safety concerns and undesirable consequences connected with melatonin use have the potential to stifle industry growth. While melatonin is generally deemed safe for short-term usage in adults, there are questions about its long-term safety and potential interactions with other drugs. Adverse symptoms such as daytime drowsiness, headaches and dizziness have been observed, but infrequently. Furthermore, the regulatory landscape differs globally, resulting in different standards and oversight, which can undermine consumer confidence.

Addressing these safety concerns through rigorous research, better labelling and healthcare provider education is critical to avoiding significant market losses. Transparency regarding potential hazards and benefits, together with appropriate marketing techniques, will be vital for maintaining consumer trust and guaranteeing the sustained expansion of the melatonin industry amidst rising health awareness and demand for sleep aids.

Category-Wise Acumens

Will Established Extraction Processes Drive the Plant Segment?

Established extraction technologies for melatonin from plants are expected to fuel expansion in the plant segment of the melatonin market. These techniques have streamlined production, resulting in constant quality and quantity of melatonin supplements. Manufacturers profit from efficient extraction processes that enhance productivity while maintaining melatonin's bioactivity, allowing them to efficiently meet consumer demands.

Furthermore, these proven techniques improve the stability and scalability of plant-derived melatonin products, increasing market competitiveness. Consumer preference for natural sources strengthens this category, as plant-based supplements coincide with expanding trends in holistic health and wellness. The regulatory clarity and safety characteristics associated with plant-derived melatonin further boost market confidence.

As awareness of melatonin's benefits continues to develop, bolstered by known extraction technologies, the plant sector is well-positioned to expand, supplying to increasing consumer interest in natural sleep aids and overall well-being.

Will Increasing Demand for High Purity and Consistency in Dosage Drive the Type Segment?

The growing need for high purity and uniformity in dosage is an important driver for the type segment of the melatonin market, particularly for synthetic melatonin. Consumers and healthcare practitioners alike value products with consistent and accurate dosing to ensure efficacy and safety in treating sleep problems and other health issues. Synthetic melatonin achieves these criteria effectively thanks to controlled manufacturing techniques that ensure purity and consistency across batches.

Furthermore, the pharmaceutical and nutraceutical businesses favor synthetic melatonin because it can meet demanding regulatory and quality control requirements. As the global market for sleep aids and dietary supplements grows, the emphasis on dependable product performance and consumer trust in dose constancy is anticipated to drive the expansion of synthetic melatonin. However, natural resources such as plant-derived melatonin also play a role, particularly among consumers seeking organic or natural options with perceived health benefits.

Country/Region-wise Acumens

Will Increasing Strong Consumer Base Consuming Dietary Supplements Drive the Market in North America?

North America's robust customer base, which values nutritional supplements, is a primary driver of the region's melatonin industry. Melatonin is becoming increasingly popular as a natural sleep aid and overall wellness supplement among North American consumers. Factors such as hurried lifestyles, rising stress levels and the incidence of sleep disorders all contribute to the need for effective remedies such as melatonin.

Furthermore, North America includes a well-developed healthcare infrastructure and regulatory framework that facilitates the distribution and sale of dietary supplements, including melatonin. Consumers in this region value health and wellness, resulting in steady growth in the market for dietary supplements such as melatonin. As a result, manufacturers and suppliers are eager to innovate and broaden their product offers to meet this growing demand, further propelling market expansion in North America.

Will Increasing Awareness of Sleep Disorders Drive the Market in Asia Pacific Region?

Growing awareness of sleep problems is projected to propel the melatonin market in Asia-Pacific (APAC). As people become more aware of the negative impacts of sleep problems like insomnia and sleep apnea, there is a greater need for effective treatments like melatonin supplements. Sleep disorders are on the rise in countries such as China, Japan and India as a result of changing lifestyles, urbanization and higher stress levels.

Furthermore, the trend towards natural health solutions is gaining traction in APAC, which is consistent with the perceived benefits of melatonin as a natural sleep aid. The region's growing middle-class population and rising disposable incomes drive demand for wellness items. As a result, there is great potential for market expansion in APAC, underpinned by higher consumption, awareness, expanding healthcare infrastructure and the introduction of innovative melatonin products tailored to regional preferences and regulatory requirements.

Competitive Landscape

The melatonin market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the melatonin market include:

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici S.P.A

Latest Developments

• In January 2023, Pfizer, Inc. increased its commitment to the "Agreement for a Healthier World" by offering its entire portfolio of medicines and vaccines on a not-for-profit basis to improve the health of 1.2 billion people in 45 low-income countries.
• In November 2022, Natrol introduced MelatoninMax, a sleep aid in the form of a single gummy containing 10 mg of melatonin, the maximum recommended dosage.

Melatonin Market, By Category

• Source:
• Plants
• Animals
• Bacteria
• Type:
• Natural Melatonin
• Synthetic Melatonin
• End-User:
• Pharmaceuticals
• Food & Beverage
• Medical & Healthcare
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Melatonin Market, By Source

• Plants
• Animals
• Bacteria

5. Melatonin Market, By Type

• Natural Melatonin
• Synthetic Melatonin

6. Melatonin Market, By End-User

• Pharmaceuticals
• Food & Beverage
• Medical & Healthcare

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Pharmative
• Nature's Bounty
• Jameison
• Rexall Sundown
• GNC
• Xiu Zheng
• Finex OY
• Church & Dwight
• By-Health
• Pfizer
• Solgar
• Biotics Research
• New Food
• Neurim Pharmaceuticals Ltd.
• Pulse Pharmaceuticals Pvt. Ltd.
• Schiff Nutrition International, Inc.
• Fidia Farmaceutici S.P.A

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References